Montelukast Prescribing at REGENT HOUSE SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
746
Total Quantity
22.9K
NHS Cost
£1.1K
vs National Avg
+8.9%
REGENT HOUSE SURGERY prescribed 746 items of Montelukast over the last 12 months at a cost of £1,085 to the NHS. This is 8.9% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
64
Jul 2026
56
Jul 2026
59
Jul 2026
67
Jul 2026
64
Jul 2026
68
Jul 2026
56
Jul 2026
62
Jul 2026
62
Jul 2026
55
Jul 2026
65
Jul 2026
68
Prescribing Details
| Total Items | 746 |
|---|---|
| Total Quantity | 22,869 |
| Total NHS Cost | £1,085 |
| Presentations | 3 different forms |
| vs National Average | +8.9% |
Montelukast Prescribing Comparison
| This practice | 746 items |
|---|---|
| National average per practice | 685 items |
| Difference | +8.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.